Samsung Electronics announced on Tuesday it has signed an agreement to acquire Xealth, a U.S.-based digital healthcare platform, aiming to expand its mobile healthcare services. The financial terms of the deal were not disclosed.
Samsung said the acquisition is intended to create synergy by combining its advanced wearable technology with Xealth’s platform, which manages digital health programs and connects care providers—including over 500 U.S. hospitals—with patients through data integration.
This move aligns with Samsung’s broader strategy to diversify beyond its traditional semiconductor and smartphone operations. The company is increasingly investing in growth areas such as medical technology, consumer audio, climate control systems, and robotics.
Earlier this year, Samsung agreed to acquire Germany’s FlaktGroup for €1.5 billion ($1.68 billion), targeting the booming demand for data center cooling, driven by AI projects. At a March shareholder meeting, Chairman Jay Y. Lee emphasized Samsung’s focus on “meaningful” acquisitions to drive growth, especially after falling behind rivals in the AI chip market led by Nvidia.
Notably, on the same day as the Xealth announcement, Samsung forecasted a sharp 56% decline in its second-quarter operating profit, mainly due to weak AI chip sales—raising investor concerns about the company’s semiconductor business recovery.